This book focuses on the four oral Chinese patent medicines used in the clinical treatment period based on the Guidelines for the Diagnosis and Treatment of COVID-19 by the National Health Commission and National Administration of Traditional Chinese Medicine of China.
This work is not only an important part of the theoretical system of TCM treatment based on syndrome differentiation but also an effective way to promote an even deeper integration of clinical pharmaceutical service and clinical medical practice.